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Juvenile amyotrophic lateral sclerosis (ALS4) is a rare autosomal dominant form of juvenile amyotrophic lateral
sclerosis (ALS) characterized by distal muscle weakness and atrophy, normal sensation, and pyramidal signs. Individuals
affected with ALS4 usually have an onset of symptoms at age !25 years, a slow rate of progression, and a normal
life span. The ALS4 locus maps to a 1.7-Mb interval on chromosome 9q34 ﬂanked by D9S64 and D9S1198. To
identify the molecular basis of ALS4, we tested 19 genes within the ALS4 interval and detected missense mutations
(T3I, L389S, and R2136H) in the Senataxin gene (SETX). The SETX gene encodes a novel 302.8-kD protein.
Although its function remains unknown, SETX contains a DNA/RNA helicase domain with strong homology to
human RENT1 and IGHMBP2, two genes encoding proteins known to have roles in RNA processing. These
observations of ALS4 suggest that mutations in SETX may cause neuronal degeneration through dysfunction of
the helicase activity or other steps in RNA processing.
Introduction
Amyotrophic lateral sclerosis (ALS), also known as “Lou
Gehrig’s disease,” denotes a heterogeneous group of se-
vere, progressive neurological disorders associated with
degeneration of motor neurons in the cerebral cortex,
brain stem, and spinal cord (Morrison and Harding
1994). Approximately 90% of ALS cases are sporadic,
and ∼10% are familial (FALS) (Strong et al. 1991). FALS
is clinically and genetically heterogeneous (Majoor-Krak-
auer et al. 2003). To date, causal mutations have been
found for only two forms of ALS. ALS1 is an adult-onset,
fatal, autosomal dominant (AD) disorder associated with
mutations in the Cu/Zn superoxide dismutase (SOD1)
gene on chromosome 21q21 (Rosen et al. 1993). ALS2
is a juvenile-onset, slowly progressive, autosomal recessive
disorder that maps to chromosome 2q33 and is associated
with mutations in the alsin gene, a putative GTPase regu-
lator (Hadano et al. 2001; Yang et al. 2001). The mech-
Received January 28, 2004; accepted for publicationMarch 10, 2004;
electronically published April 21, 2004.
Address for correspondence and reprints: Dr. Phillip F. Chance, De-
partment of Pediatrics, Box 356320, Room RR247, University ofWash-
ington, Seattle, WA 98195. E-mail: pchance@u.washington.edu
 2004 by The American Society of Human Genetics. All rights reserved.
0002-9297/2004/7406-0007$15.00
anisms through which mutations in either SOD1 or alsin
lead to motor neuron degeneration are unknown.
ALS4 (MIM 602433 [also known as “distal hereditary
motor neuronopathy” with pyramidal features or
dHMN]) is a rare, childhood- or adolescent-onset, AD
form of ALS that is characterized by slow disease pro-
gression, limb weakness, severe muscle wasting, and py-
ramidal signs associated with degeneration of motor
neurons in the brain and spinal cord. The phenotype of
ALS4 includes a long duration of disease, absence of
overt sensory abnormalities, and the sparing of bulbar
and respiratory muscles (Chance et al. 1998; Rabin et
al. 1999; De Jonghe et al. 2002).
We mapped a gene for ALS4 to chromosome 9q34
in a large Maryland family (K7000) in which 49 family
members were affected (Chance et al. 1998; Rabin et al.
1999; Blair et al. 2000). Analysis in an additional three
families (CMT-61, CMT-106, and F-54) with a similar
phenotype supported linkage to the same region in 9q34
(De Jonghe et al. 2002). To identify a critical gene for
this disorder, we searched for mutations in 19 candidate
genes mapping within the ALS4 interval on chromosome
9q34 (ﬁg. 1a). Our analysis detected missensemutations
in the Senataxin gene (SETX) or KIAA0625 (HUGE
Protein Database), a gene that encodes a novel DNA/
RNA helicase in three unrelated families with ALS4.
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Material and Methods
Families with ALS4
We obtained family data and blood samples, under a
protocol of informed consent approved by the institu-
tional review board of the University of Washington,
Seattle, and the other relevant approved review boards
for each medical institution, according to the Declara-
tion of Helsinki.
Pedigrees K7000, CMT-61, CMT-106, and F-54 are
from the United States, Belgium, Austria, and England,
respectively. Detailed clinical, genetic, and electrophysio-
logical features of individuals affected with ALS4 from
these four unrelated pedigrees have been described else-
where (Rabin et al. 1999; De Jonghe et al. 2002). Af-
fected individuals have a slowly progressive motor neu-
ronopathy with evidence of upper and lower motor-neu-
ron dysfunction. There is predominantly distal muscle
weakness and atrophy associated with pyramidal signs,
including brisk deep-tendon reﬂexes and a positive Ba-
binski maneuver. The mean ages at onset for each pedi-
gree are 17 years (K7000), !6 years (CMT-61), 8 years
(CMT-106), and 21 years (F-54). In pedigree K7000,
∼10% of affected persons had minimal sensory impair-
ment, usually limited to a slight elevation of vibratory
threshold in middle-aged or elderly patients. Otherwise,
affected persons have no overt clinical signs of sensory-
nerve impairment. There is wide variation of phenotypic
expression, ranging from some individuals with only
mild gait abnormalities and brisk reﬂexes to those who
may be wheelchair-bound with no functional hand use
by the 5th or 6th decade of life.
Whereas the phenotype in pedigree F-54 includes dis-
tal weakness and amyotrophy with normal sensation,
affected individuals in this family are somewhat different
from those seen in the other three pedigrees. All patients
in F-54 presented with foot deformities (pes cavus) dur-
ing early childhood, and some patients had been diag-
nosed as having spastic paraplegia with amyotrophy (Sil-
ver disease). This pedigree was reported elsewhere as hav-
ing LOD scores supporting linkage to the ALS4 region
(De Jonghe et al. 2002); however, we performed analysis
with additional affected persons, and linkage to the ALS4
region was no longer found (table 1). Furthermore, hap-
lotypes constructed with markers from the ALS4 interval
do not segregate with the disease in this pedigree (data
not shown).
Electrophysiological studies, including nerve-conduc-
tion velocity (NCV) and electromyography (EMG), of
patients with ALS4 documented the presence of a chronic
motor neuronopathy with partial denervation-reinner-
vation, in a graded pattern of distal muscles being more
severely affected than proximal muscles (Rabin et al.
1999; De Jonghe et al. 2002). EMG testing disclosed re-
duced amplitudes of compound muscle-action potentials,
positive sharp waves, and ﬁbrillations. Sural and median
sensory nerve–action potential amplitudes were normal.
Motor and sensory NCV testing showed normal values
or minimal slowing.
Pathological Studies
Postmortem examinations of the brain and spinal cord
have been undertaken in two individuals (aged 75 and
88 years) from pedigree K7000 (Rabin et al. 1999). In
both individuals, there were atrophic spinal cords with
marked loss of anterior horn cells and degeneration of
corticospinal tracts. Despite an absence of signiﬁcant
sensory impairment on clinical examinations, in both
individuals, there was a deﬁnite loss of neurons in the
dorsal-root ganglia and degeneration of the posterior
columns. Axonal spheroids were present in the graymat-
ter of the spinal cord, the dorsal-root entry zones, and
the peripheral nerves. Motor and sensory roots, as well
as peripheral nerves, showed signiﬁcant axonal loss.
Generation of Somatic Cell Hybrids
This procedure was performed as described elsewhere
(Yan et al. 2000; Marra et al. 2001). In brief, lympho-
blasts from the K7000 proband were electrofused to
mouse E2 cell lines. Unfused mouse E2 clones and un-
fused human lymphocyte clones were negatively selected
using HAT and geneticin, respectively. Fused colonies
appearing after 2 wk were selected and expanded for an
additional 2 wk prior to DNA analysis. Chromosome 9
polymorphic markers were used to isolate two hybrid
clones, one containing the affected human monochromo-
some 9 and the second containing the normal human
monochromosome 9. The ALS4-affected hybrid was se-
lected by haplotype analysis with known disease-asso-
ciated polymorphic markers (data not shown).
Mutation Detection
We performed PCR ampliﬁcation and DNA sequenc-
ing of 340 exons derived from 19 candidate genes within
the ALS4 disease interval. We compared DNA sequences
obtained from affected patients and normal individuals,
using primer pairs designed from Internet-accessible
sources (see the “Electronic-Database Information” sec-
tion). One hundred DNA samples taken from a racially
mixed population were used as controls.
Northern-Blot Analysis
We performed northern-blot analysis of human 12-
lane multiple tissue blot (Clontech) with an SETX
(KIAA0625) IMAGE clone insert (number 4136196) la-
beled with dCTP-[a-32P]. Standard conditions for hybridi-
zation and washing were employed, with the ExpressHyb
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Table 1
LOD Scores (Z) in Pedigree F-54
MARKER
LOD AT vp
.0 .01 .05 .10 .2 .3 .4
D9S1847 3.53 2.34 .97 .41 .01 .10 .05
D9S2126 4.51 2.07 .69 .16 .21 .24 .13
D9S1199 4.51 2.76 1.27 .62 .08 .07 .05
Figure 1 Identiﬁcation of the ALS4 gene. a, ALS4 gene region on 9q34. Markers D9S64 and D9S1198 deﬁne a 1.7-Mb interval containing
19 genes. Sequencing of 340 exons and ﬂanking regions in probands with ALS4 revealed mutations in SETX or KIAA0625, a gene encoding
a novel member of the RNA/DNA helicase family. Corresponding human, mouse, and rat cDNA sequences are shown. The SETX gene consists
of 26 exons. An asterisk (*) indicates the locations of mutations in three unrelated pedigrees with ALS4. b, Mutations in SETX in pedigrees
with ALS4 (K7000, CMT-106, and CMT-61). As shown, mutations are heterozygous, except for the mutant hybrid cell line (prepared from an
affected individual from K7000). Protein alignment showed that mutations of human SETX are well conserved with rat and murine orthologs.
c, Restriction pattern of the NdeI digest of the 441-bp exon 3 fragment, with the c.8CrT mutation seen in CMT-106 giving rise to two bands
of 284 bp and 157 bp. BsaHI exon 19 restriction digestion pattern of a 284-bp fragment and 157-bp fragment, with the c.6407GrA mutation
seen in CMT-61, resulting in an undigested band of 433 bp.
buffer, according to the manufacturer’s speciﬁcations
(Clontech).
Results
Mutation Analysis of a Monochromosome 9 Hybrid
Cell Line
We searched for deletions, insertions, or other rear-
rangements in the ALS4 region by PCR-based STS/EST
content mapping in the affected chromosome 9 cell line.
We did not detect evidence for such deletions/insertions
or rearrangements following the ampliﬁcation of all 340
exon fragments (data not shown). We next searched for
disease-associated DNA sequence alterations in these
same exons and their ﬂanking regions, derived from 19
candidate genes for ALS4 (ﬁg. 1a). In the ALS4-affected
monochromosome 9 hybrid line (pedigree K7000), we
found a single-nucleotide change, a c.1166TrC trans-
version in exon 10 of the SETX gene (GenBank accession
number AY362728), predicted to cause an L389S
substitution.
Identiﬁcation of SETX Mutations in Three Pedigrees
with ALS4
Following the identiﬁcation of an SETX disease-as-
sociated mutation in the somatic cell hybrid, all 24 cod-
ing exons of this gene were sequenced in probands from
each of the four pedigrees mapping to 9q34. All affected
individuals from pedigree K7000 were heterozygous for
the L389S substitution, whereas unaffected members had
a homozygous normal pattern. The L389S mutation was
not detected in 100 unrelated control individuals. In pedi-
gree CMT-61, affected individuals were found to carry
a heterozygous c.6407GrA transition in exon 19, lead-
ing to an R2136H substitution. This mutation elimi-
nated a BsaHI restriction site, allowing us to scan a panel
of 100 unrelated control individuals without detecting
this mutation. In pedigree CMT-106, we detected a het-
erozygous c.8CrT transversion in exon 3 (exons 1 and
2 are noncoding) leading to a T3I substitution. This
mutation generated an NdeI restriction site that was not
present in unaffected family members, nor was it found
in 100 unrelated control individuals (ﬁg. 1b and 1c; table
2). No mutation was detected in pedigree F-54 as a result
of our initial examination of the coding exons or exon/
intron boundaries of SETX. We performed a more ex-
tensive search by sequencing additional genomic DNA,
including 1 kb of 5′ UTR, the two noncoding exons (1
and 2), 2.8 kb of the 3′ UTR, and the canonical poly-
adenylation signal. However no disease-associated mu-
tation of SETXwas identiﬁed in this pedigree. The SETX
mutations segregate with the disease phenotype in three
families, consistent with the ADmode of inheritance and
supporting the hypothesis that mutations in the SETX
gene are associated with ALS4.
Structure and Deduced Protein Sequence of SETX
The SETX gene encodes a 302.8-kD protein consisting
of 2,677 amino acids (ﬁg. 1a). Northern-blot analysis
identiﬁed two prominent transcripts of 11.5 kb and 9.0
kb in all tissues examined, including brain and spinal
cord (ﬁg. A1a and A1b [online only]). Both bands de-
tected by northern blot were observed with each of sev-
eral different SETX probes that were used to target both
5′ and 3′ regions of the transcript (data not shown). We
suggest that a canonical polyadenylation signal 3,174 bp
beyond the stop codon accounts for the stronger 11.5-
kb band and that a less efﬁcient cryptic polyadenylation
signal be used to generate the weaker 9.0-kb band.
The SETX protein sequence was analyzed with the do-
main prediction programs InterproScan (European Bioin-
formatics Institute), SMART, and BLASTP. Each program
predicted a superfamily I DNA/RNA helicase domain
at residues 1931–2456. InterproScan predicted an ATP/
GTP–binding site motif A (P-loop) at residues 1963–
1970 (ﬁg. 2) that has been shown to be essential for
DNA unwinding in other systems (Molnar et al. 1997).
A bipartite nuclear localization signal was also predicted
by InterproScan and by the peptide signal–sorting pro-
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Table 2
Mutations of SETX and Clinical Data for Patients with ALS4
Family
No. of
Affected/Unaffected
Individuals
Geographic
Origin
Heterozygous
Mutationa
Amino
Acid
Substitution
Average Age
at Onset
(years)
K7000 55/65 United States c.1166TrC L389S 17
CMT-61 5/3 Belgium c.6407GrA R2136H !6
CMT-106 7/10 Austria c.8CrT T3I 8
a SETX nucleotide sequence taken from the ORF of GenBank accession numbers NM_015046
and AY362728.
gram P-sort (residues 2070–2087). It is interesting that
the majority of this large protein appears novel, since
no program or homology search could identify addi-
tional domains or structural features within residues 1–
1930.
As mentioned above, the C-terminal end of the SETX
protein contains a superfamily I helicase domain from
residues 1931–2456. This helicase domain has high ho-
mology with the rat orthologue (at 85% identity), and
the mouse orthologue (at 90% identity). By BLASTP
analysis, the SETX helicase domain has 46% identity
with the regulator of nonsense transcripts-1 protein
(RENT1). Human RENT1 is thought to be part of a
distinct subset within the superfamily that includes the
yeast-splicing endonuclease 1 gene (Sen1). The helicase
domain of SETX also shows strong identity to a second
human protein, the immunoglobulin m-binding protein
2 (IGHMBP2), at 42% identity (ﬁg. 2).
Discussion
We previously mapped the gene for ALS4 to chromo-
some 9q34 in a largeMaryland kindred, K7000 (Chance
et al. 1998; Blair et al. 2000). Genetic analysis of ad-
ditional families with similar phenotypic features yielded
combined LOD scores suggesting linkage with multiple
markers within the ALS4 interval (De Jonghe et al. 2002).
In this article, we focused our analysis on these four pedi-
grees and searched for causal mutations within a 1.7-Mb
interval encompassing 19 known candidate genes (ﬁg. 1a).
Mutations in SETX, a gene encoding a novel DNA/RNA
helicase, were found in three pedigrees. In a fourth pedi-
gree (F-54), we did not ﬁnd any disease-associated mu-
tations. Although initial studies suggested linkage to the
ALS4 interval (De Jonghe et al. 2002), subsequent analy-
sis including additional affected individuals conﬁrmed
that the gene in pedigree F-54 is unlinked to 9q34.
The clinical and genetic nosology of inherited disorders
affecting motor systems is complex and evolving. Fre-
quently, the overlap of phenotypic features seen within
forms of familial motor neuronopathies, hereditary spas-
tic paraplegias, and hereditary peripheral polyneuropa-
thies (e.g., Charcot-Marie-Tooth [CMT] neuropathy)
may complicate their classiﬁcation. Individuals in pedi-
gree K7000 were ﬁrst reported as having a variant of
CMT, despite the presence of upper motor-neuron dys-
function and lack of sensory impairment (Myriantho-
poulos et al. 1964). Pedigrees CMT-61 and CMT-106
were also initially diagnosed to have variant forms of
CMT; however, genetic analysis suggested linkage to
chromosome 9q34, and they were reported to have a
form of dHMN or ALS4. Furthermore, linkage to chro-
mosome 9q34 in the ALS4 interval was found in an Ital-
ian pedigree with spastic paraplegia designated “SPG19”
(Valente et al. 2002). Regardless of the diagnostic ter-
minology for these pedigrees, the results of our analysis
show that an important gene for motor-neuron function
maps to chromosome 9q34 and is associated with mu-
tations in SETX. It will be crucial to test other kindreds
having motor-neuron disorders with similar phenotypes
for mutations in SETX.
It is interesting that it has been reported that putative
loss-of-function mutations (nonsense) in the SETX gene
lead to an unrelated disorder, ataxia-oculomotor apraxia
type 2 (AOA2 [MIM 606002]) (Moreira et al. 2004).
Ataxia-oculomotor apraxia (AOA) is a genetically het-
erogeneous group of autosomal recessive disorders char-
acterized by cerebellar ataxia/atrophy, oculomotor
apraxia, early loss of reﬂexes, late peripheral neuropathy,
slow progression leading to severe motor handicap and
the absence of telangiectasias, and immunodeﬁciency.
One form, AOA1, maps to chromosome 9q21 and is
caused by mutations in the aprataxin gene (Date et al.
2001; Moreira et al. 2001). Another form, AOA2,maps
to chromosome 9q34 within the same interval to which
the ALS4 gene maps. Moreira et al. (2004) reported 15
different mutations of SETX in patients with AOA2,
and 10 of these mutations were predicted to lead to pre-
mature termination of the SETX protein. Heterozygous
carriers of mutations in SETX associated with AOA2
have a normal phenotype. Although there are clear dif-
ferences in the phenotypes of ALS4 and AOA2 and dif-
ferent modes of inheritance (AD and recessive, respec-
tively), they have several features in common. Both
disorders lead to development of a peripheral motor
neuropathy (albeit with a later onset in subjects with
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Figure 2 Alignment of the helicase domain regions of the human SETX, IGHMBP2, RENT1, and yeast SEN1 proteins. Identities of the
SETX helicase domain with that of IGHMBP2, RENT1, and yeast SEN1 are 42%, 46%, and 42%, respectively. SETX has an ATP/GTP–
binding site motif A (P-loop), indicated by a bar. An asterisk (*) indicates the position of the mutation in CMT-61.
AOA2), and reduced evoked amplitudes have been docu-
mented in AOA2 (Watanabe et al. 1998) and in patients
in pedigree K7000 (Rabin et al. 1999). Disease progres-
sion is slow, leading to severe motor handicap, whereas
longevity is unaffected in both disorders. Given the
types of SETX mutations seen thus far in ALS4 and
AOA2, it is tempting to speculate that a dominant-act-
ing, partial loss of function or a toxic gain of function
could lead to development of primarily upper and lower
motor-neuron degeneration, as seen in patients with
ALS4, whereas the recessive, putative loss-of-function
mutations could lead to a more widespread disorder, as
seen in AOA2 (Watanabe et al. 1998; Moreira et al.
2004).
The mechanisms through which mutations in SETX
lead to ALS4 or AOA2 are unknown; however, DNA/
RNA helicases are known to be involved in DNA repair,
replication, recombination and transcription, RNApro-
cessing, transcript stability, and translation initiation
(Tanner and Linder 2001). Recent studies showed that
several human diseases, including spinal muscular atro-
phy (SMA), are associated with defects in proteins or
protein complexes that possess helicase activity (Camp-
bell et al. 2000; Meister et al. 2000; Grohmann et al.
2001). Pellizzoni et al. (2001) identiﬁed RNA helicase
A as a novel SMN-interacting protein and showed that
this interaction is defective in some SMA mutants, sug-
gesting a critical role for the SMN complex in several
aspects of mRNA biogenesis. Although the SMN pro-
tein does not contain helicase motifs, it is part of a major
cellular complex including DP103, a member of the
DEAD box family of RNA helicase (Campbell et al.
2000). It is interesting that SMA with respiratory dis-
tress type 1 (SMARD1) results from mutations in the
IGHMBP2 gene that do contain a helicase motif (Groh-
mann et al. 2001). These results suggest that DNA/RNA
helicase dysfunction may play an important role in the
development of lower motor-neuron diseases.
The helicase domain of SETX also showed strong
homology with RENT1 (46% identity), which, like
IGHMBP2, also plays an important role in producing
mature mRNA. Recent ﬁndings showed that RENT1 is
involved in nonsense-mediated RNA decay (NMD) (Sun
et al. 1998; Mendell et al. 2002). NMD probably pro-
tects the organism from deleterious peptides that could
be expressed from nonsense alleles. Studies also showed
that inhibition of RENT1 expression abrogated NMD
of nonsense T-cell receptor beta transcripts (Mendell et
al. 2002).
Given that the helicase domains of the SETX and
IGHMBP2 proteins show strong homology (42% iden-
tity) and that mutations in the genes encoding these pro-
teins lead to selected motor-neuron degeneration, our
observations of ALS4 suggest that DNA/RNA mutant
helicases play an important role in both lower and upper
motor-neuron diseases. Like the IGHMBP2 protein,
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SETX may function in mRNA biogenesis. Similarly, the
strong homology that SETX shows with RENT1 (46%
identity) suggests a role for SETX in nonsense-mediated
RNA decay. We suggest that mutations in SETX may
lead to the dysfunction of the helicase activity of this
protein. It is conceivable that the abnormal SETX pro-
tein in ALS4 impairs the capacity of neurons to produce
error-free mature mRNA, thus leading to neuronal
degeneration.
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